Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Long-term Study of GFB-887 in Patients With Glomerular Kidney Diseases

NCT04950114 is registered in ClinicalTrials.gov with Goldfinch Bio, Inc. as lead sponsor.

NCT NCT04950114
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04950114 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Long-term Study of GFB-887 in Patients With Glomerular Kidney Diseases
Lead sponsor
Goldfinch Bio, Inc.
Phase
Phase 2
Overall status
Terminated
Start date
July 27, 2021
Completion date
November 2, 2022
Enrollment
31 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

focal segmental nephrosis, glomerulonephritis, glomerulosclerosis, kidney diseases, lipoid urologic disease, nephritis, nephrosis